suven life sciences ltd
(SVLS:National Stock Exchange of India)

Financial Statements for suven life sciences ltd (SVLS)

Currency in Millions of Indian Rupees	As of:	Mar 31 2009 Restated INR	Mar 31 2010 Restated INR	Mar 31 2011 Restated INR	Mar 31 2012 INR	4 Year Trend
Revenues		1,399.4	1,293.1	1,504.3	2,042.1
TOTAL REVENUES		1,406.5	1,293.1	1,504.3	2,042.1
Cost of Goods Sold		667.8	555.3	763.2	1,030.8
GROSS PROFIT		738.6	737.8	741.1	1,011.3
Selling General & Admin Expenses, Total		261.4	245.7	289.2	340.8
R&D Expenses		294.6	341.5	314.5	339.6
Depreciation & Amortization, Total		50.2	52.9	54.5	60.0
Other Operating Expenses		0.8	3.5	1.9	1.5
OTHER OPERATING EXPENSES, TOTAL		607.0	643.6	660.0	741.9
OPERATING INCOME		131.6	94.2	81.2	269.4
Interest Expense		-56.2	-40.5	-53.2	-88.8
Interest and Investment Income		2.1	1.4	3.0	7.1
Other Non-Operating Expenses, Total		32.5	-18.0	1.0	-96.2
Other Non-Operating Income (Expenses)		-6.7	-0.4	-5.1	-6.3
Gain (Loss) on Sale of Assets		-0.1	--	0.6	-0.1
Other Unusual Items, Total		-59.0	--	--	--
EBT, INCLUDING UNUSUAL ITEMS		51.0	37.1	32.5	91.4
Income Tax Expense		-20.3	-32.9	-71.4	-52.2
Earnings from Continuing Operations		71.2	70.0	104.0	143.6
NET INCOME		71.2	70.0	104.0	143.6
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		71.2	70.0	104.0	143.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		71.2	70.0	104.0	143.6

Report Data Issue

To contact SUVEN LIFE SCIENCES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.